H. Prais

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

Paul N. Durrington, Mike Mackness, Deepak Bhatnagar et al. · Atherosclerosis · 1998 · 149 citations

Type Iib Hyperlipoproteinaemia, Thrombosis, Biochemistry +11

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

PN Durrington, H. Prais, Deepak Bhatnagar et al. · The Lancet · 1999 · 94 citations

Cardiovascular Disease, Cholesterol-lowering Medication, Outcomes Research +8

Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease

Deepak Bhatnagar, P.N. Durrington, Keith M. Channon et al. · Atherosclerosis · 1993 · 66 citations

High Density, Oxysterol, Biochemistry +9

Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.

Mike Mackness, Deepak Bhatnagar, P.N. Durrington et al. · PubMed · 1994 · 64 citations

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins

Deepak Bhatnagar, Paul N. Durrington, Mike Mackness et al. · Atherosclerosis · 1992 · 47 citations

High Density, Metabolic Syndrome, Biochemistry +11